California-based EndoGastric Solutions Inc. and Aptus EndoSystems Inc. brought in $30 million and $15 million, respectively, in separate funding rounds.
Menlo Park, Calif.-based Canaan Partners and New York-based Radius Ventures led EndoGastric’s $30 million Series F round, which was designed to support the company through profitability, according to a press release.
The company makes endoscopic surgical equipment for tissue-stapling in the stomach and esophagus, designed to treat reflux disease and, eventually, for bariatric applications. Radius Ventures partner Kathleen Regan, who will join the company’s board along with Brent Ahrens of Canaan Ventures, called reflux and obesity surgical equipment makers with the same level of growth as EndoGastric Solutions are "rare," according to the release.
U.S. Venture Partners and Longitude Capital, both also based in Menlo Park, led the $15 million Series AA The company is developing the AAA Repair System, an endovascular device for treating aortic aneurysms. The funding follows Aptus’ completion of regulatory milestones, including CE Mark approval for the system and the completion of the STAPLE-2 clinical study in the U.S. The new financing will fund continuing clinical and commercial development in Europe and U.S., according to a press release. Several partners with U.S. Venture Partners and Longitude Capital sit on Aptus’s board.
